Antineoplastic AgentsAntineoplastic Agents, PhytogenicLeukemia P388Amaryllidaceae AlkaloidsNarcissusEllipticinesDrug Screening Assays, AntitumorBibenzylsDoxorubicinAntibiotics, AntineoplasticThiadiazinesBryostatinsAntineoplastic Agents, AlkylatingNeoplasmsAncitabineGalliumTumor Cells, CulturedCisplatinDepsipeptidesDrug SynergismPaclitaxelCell Line, TumorApoptosis6-MercaptopurineCell SurvivalMolecular StructureAminoacridinesEpothilonesSarcoma 180Dose-Response Relationship, DrugAntimetabolites, AntineoplasticFluorouracilLactonesLeukemia L1210Antineoplastic Combined Chemotherapy ProtocolsDaunorubicinDrug Resistance, NeoplasmDrug Evaluation, PreclinicalProdrugsBleomycinCell DivisionXenograft Model Antitumor AssaysEtoposideClinical Trials as TopicDrug EvaluationDrug ResistanceMethotrexateNeoplasms, ExperimentalEnzyme InhibitorsCell CycleMacrolidesMice, NudeCamptothecinDrug InteractionsCell ProliferationStilbenesDrug Administration ScheduleLung NeoplasmsVincristineHL-60 CellsBreast NeoplasmsTime FactorsDNA DamageCyclophosphamideIsoquinolinesNeoplasm TransplantationBiotransformationKineticsCell LineStereoisomerismTaxoidsLeukemiaOvarian NeoplasmsProstatic NeoplasmsTreatment OutcomeStructure-Activity RelationshipColonic NeoplasmsDNACaspasesRNA, MessengerCells, CulturedPhospholipid EthersReactive Oxygen SpeciesGloves, ProtectiveAster PlantOccupational ExposureDrugs, InvestigationalOlacaceaeMedical SecretariesAngiogenesis InhibitorsOncology NursingAlkylating AgentsLaunderingDrug Delivery SystemsSulindacProtective DevicesDental Physiological ProcessesContrast MediaInhibitory Concentration 50Equipment and Supplies, Hospital